MADISON CLARK: Open Payments
NPI 1194434498 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 37 payments from 11 companies in 2025. Trend: 2023 $283 · 2024 $549 · 2025 $1,036
Food & beverage: $1,024Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $180 |
| Alkermes, Inc. | 5 | $149 |
| Vanda Pharmaceuticals Inc. | 6 | $147 |
| Neurocrine BioSciences, Inc. | 4 | $126 |
| Axsome Therapeutics, Inc. | 4 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: CAPLYTA, ARISTADA, INGREZZA, Auvelity, HETLIOZ, COBENFY, REXULTI, FANAPT.
Industry payments across TN — which companies pay providers there.
